Carvacrol ameliorates haematological parameters, oxidant/antioxidant biomarkers and pulmonary function tests in patients with sulphur mustard-induced lung disorders: A randomized double-blind clinical trial.
M R KhazdairA AlavinezhadMohammad Hossein BoskabadyPublished in: Journal of clinical pharmacy and therapeutics (2018)
Two-month treatment with CAR reduced inflammatory cells and oxidant biomarkers, whereas increased antioxidant biomarkers and improved PFT tests in SM-exposed patients.
Keyphrases
- clinical trial
- oxidative stress
- anti inflammatory
- double blind
- end stage renal disease
- induced apoptosis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- diabetic rats
- study protocol
- prognostic factors
- phase ii
- high glucose
- placebo controlled
- phase iii
- endoplasmic reticulum stress
- endothelial cells
- replacement therapy
- patient reported